175 related articles for article (PubMed ID: 17702397)
1. [Preparation and biological activity of poly (gamma-glutamic acid) -cisplatin conjugate].
Jin L; Ye HF; Huang J; Jiang L; Hu RZ; Wu ZR
Yao Xue Xue Bao; 2007 Jun; 42(6):611-7. PubMed ID: 17702397
[TBL] [Abstract][Full Text] [Related]
2. Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.
Ye H; Jin L; Hu R; Yi Z; Li J; Wu Y; Xi X; Wu Z
Biomaterials; 2006 Dec; 27(35):5958-65. PubMed ID: 16949149
[TBL] [Abstract][Full Text] [Related]
3. A poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery.
Xiong Y; Jiang W; Shen Y; Li H; Sun C; Ouahab A; Tu J
Biomaterials; 2012 Oct; 33(29):7182-93. PubMed ID: 22795851
[TBL] [Abstract][Full Text] [Related]
4. Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.
Feng Z; Lai Y; Ye H; Huang J; Xi XG; Wu Z
Cancer Sci; 2010 Nov; 101(11):2476-82. PubMed ID: 20813014
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
6. Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.
Song W; Li M; Tang Z; Li Q; Yang Y; Liu H; Duan T; Hong H; Chen X
Macromol Biosci; 2012 Nov; 12(11):1514-23. PubMed ID: 23070837
[TBL] [Abstract][Full Text] [Related]
7. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and in vivo evaluation of poly(ethylene oxide-co-glycidol)-platinate conjugate.
Zhou P; Li Z; Chau Y
Eur J Pharm Sci; 2010 Nov; 41(3-4):464-72. PubMed ID: 20709170
[TBL] [Abstract][Full Text] [Related]
9. A novel GAP460 biopolymer for use as a carrier in drug-delivery applications.
Feng Z; Li W; Xue X; Geng X; Wu Y; Huang J; Wu Z
J Biomater Sci Polym Ed; 2011; 22(15):2023-40. PubMed ID: 21029517
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin.
Bhatt R; de Vries P; Tulinsky J; Bellamy G; Baker B; Singer JW; Klein P
J Med Chem; 2003 Jan; 46(1):190-3. PubMed ID: 12502373
[TBL] [Abstract][Full Text] [Related]
11. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and evaluation of a γ-PGA-based self-assembly transferrin receptor-targeting anticancer drug carrier.
Zhang L; Zhu X; Wu S; Chen Y; Tan S; Liu Y; Jiang W; Huang J
Int J Nanomedicine; 2018; 13():7873-7889. PubMed ID: 30538465
[TBL] [Abstract][Full Text] [Related]
13. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
[TBL] [Abstract][Full Text] [Related]
15. Preparation of pixantrone/poly(γ-glutamic acid) nanoparticles through complex self-assembly for oral chemotherapy.
Meng L; Ji B; Huang W; Wang D; Tong G; Su Y; Zhu X; Yan D
Macromol Biosci; 2012 Nov; 12(11):1524-33. PubMed ID: 23008063
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of poly(γ-glutamic acid)-based biopolymer as the targeted drug delivery system with enhanced cytotoxicity to APN/CD13 over-expressed cells.
Zhang L; Geng X; Zhou J; Wang Y; Gao H; Zhou Y; Huang J
J Drug Target; 2015 Jun; 23(5):453-61. PubMed ID: 25648136
[TBL] [Abstract][Full Text] [Related]
17. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-stitched α-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition.
Wang H; Xiong Y; Wang R; Yu Y; Wang J; Hu Z; Sun C; Tu J; He D
Eur J Pharm Sci; 2018 Jul; 119():189-199. PubMed ID: 29678612
[TBL] [Abstract][Full Text] [Related]
19. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering.
Matsusaki M; Akashi M
Biomacromolecules; 2005; 6(6):3351-6. PubMed ID: 16283765
[TBL] [Abstract][Full Text] [Related]
20. Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications.
Sung MH; Park C; Kim CJ; Poo H; Soda K; Ashiuchi M
Chem Rec; 2005; 5(6):352-66. PubMed ID: 16278834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
